Centre for Pulmonary Hypertension, Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital, Röntgenstrasse 1, 69126, Heidelberg, Germany.
Translational Lung Research Center Heidelberg (TLRC), the German Center for Lung Research (DZL), Heidelberg, Germany.
Sci Rep. 2023 Feb 1;13(1):1839. doi: 10.1038/s41598-023-28608-x.
Oxygenated hemoglobin (OxyHem) in arterial blood may reflect disease severity in patients with systemic sclerosis (SSc). The aim of this study was to analyze the predictive value of OxyHem in SSc patients screened for pulmonary hypertension (PH). OxyHem (g/dl) was measured by multiplying the concentration of hemoglobin with fractional oxygen saturation in arterialized capillary blood. Prognostic power was compared with known prognostic parameters in SSc using uni- and multivariable analysis. A total of 280 SSc patients were screened, 267 were included in the analysis. No signs of pulmonary vascular disease were found in 126 patients, while 141 patients presented with mean pulmonary arterial pressure ≥ 21 mmHg. Interstitial lung disease (ILD) was identified in 70 patients. Low OxyHem ≤ 12.5 g/dl at baseline was significantly associated with worse survival (P = 0.046). In the multivariable analysis presence of ILD, age ≥ 60 years and diffusion capacity for carbon monoxide (DLCO) ≤ 65% were negatively associated with survival. The combination of low DLCO and low OxyHem at baseline could predict PH at baseline (sensitivity 76.1%). This study detected for the first time OxyHem ≤ 12.5 g/dl as a prognostic predictor in SSc patients. Further studies are needed to confirm these results.
动脉血氧合血红蛋白 (OxyHem) 可能反映系统性硬化症 (SSc) 患者的疾病严重程度。本研究旨在分析动脉血氧合血红蛋白在肺动脉高压 (PH) 筛查的 SSc 患者中的预测价值。通过将动脉化毛细血管血中血红蛋白浓度与氧饱和度相乘来测量 OxyHem (g/dl)。使用单变量和多变量分析比较 OxyHem 与 SSc 中已知的预后参数的预测能力。共筛查了 280 例 SSc 患者,267 例纳入分析。126 例患者无肺血管疾病迹象,而 141 例患者平均肺动脉压≥21mmHg。70 例患者存在间质性肺病 (ILD)。基线时低 OxyHem≤12.5g/dl 与较差的生存显著相关 (P=0.046)。在多变量分析中,ILD 存在、年龄≥60 岁和一氧化碳弥散量 (DLCO)≤65%与生存呈负相关。基线时低 DLCO 和低 OxyHem 的组合可预测基线时的 PH (敏感性 76.1%)。本研究首次发现 OxyHem≤12.5g/dl 是 SSc 患者的预后预测指标。需要进一步的研究来证实这些结果。